A ge-related macular degeneration (AMD) affects elder adults and there is no effective treatment against it. In the developed world, AMD accounts for approximately half of all vision impairment or blind registrations. 1 In Asia, the pooled prevalence is 6.8% for early AMD and 0.56% for advanced AMD in populations between 40 and 79 years old. 2 For Chinese, some regional studies indicated that the prevalence of early AMD ranges from 4.7%-9.2% and that of the advanced AMD from 0.2-1.9% in elderly people. 3, 4 Despite the fact that AMD greatly impairs quality of life, its etiology remains unclear. The prevailing view on AMD etiology is that the genetic factor might have an important role. 5, 6 So far, studies about the genetic background of AMD have reported tremendous progress in identifying the polymorphisms in three genes to be highly associated with AMD in different ethnic groups: complement H (CFH), age-related maculopathy susceptibility 2 (ARMS2, also known as LOC387715), and hightemperature requirement factor A1 (HTRA1). [7] [8] [9] [10] [11] [12] [13] Several studies indicated that the genetic variants of other genes conferred disease risk in Caucasian populations, namely complement 3 (C3); serpin peptidase inhibitor, clade G, member 1 (SERPING1); vascular endothelial growth factor (VEGF); cholesterol ester transfer protein (CETP); lipoprotein lipase (LPL); hepatic lipase (LIPC), and metallopeptidase inhibitor 3 (TIMP3). [14] [15] [16] [17] [18] [19] [20] [21] [22] However, a few studies in China and Japan reported that there were no significant contributions from C3 (rs2230199, rs1047286), SERPING1 (rs2511989, rs1005510), and VEGF (rs3025039) to AMD, 7, [23] [24] [25] [26] whereas a study in Taiwan reported that VEGF (rs3025039) polymorphism was associated with wet AMD. 27 So far, to our knowledge no more convincing data have been reported about the relationship between AMD and these genetic variants in the Chinese population. Therefore, we conducted the current study to investigate the association between multiple genetic polymorphisms and AMD in a nationwide Chinese population. Hospital, and the Department of Epidemiology and Biostatistics of Peking University led the study. To represent the Chinese population comprehensively, 16 local hospitals located sporadically in the northern and southern parts of China were selected as the research centers. All researchers in these local hospitals received training about the diagnosis of AMD, inclusion and exclusion criteria of the participants, and specimen collection, which was conducted by the ophthalmologists of People's Hospital, and experts of the Department of Epidemiology and Biostatistics. PASS software (Version 08.0.3; NCSS, LLC, Kaysville, UT) was used to calculated the sample size (a ¼ 0.05, b ¼ 0.20). According to the frequencies of the risk allele of single nucleotide polymorphisms (SNPs) that have been reported, 485 patients and 485 controls were needed. The hospitals with a large AMD patient capacity were planned to recruit 40 patients and 40 controls, and the hospitals with a small capacity were planned to recruit 20 patients and 20 controls. After strictly re-checking by the reading center of Peking University People's Hospital, 535 patients and 469 controls were eligible. The project was approved by the Ethics Committee of Peking University People's Hospital, and the procedures were consistent with the Declaration of Helsinki. All AMD patients and controls provided written informed consent.
MATERIALS AND METHODS

AMD Patients and Control Subjects
Participants were enrolled from the ophthalmologic department of the 16 hospitals between 2008 and 2010. All of them received ophthalmologic examinations, including slit-lamp biomicroscopy and funduscopy. If they were revealed as having AMD by funduscopy, the patients would be examined further with fluorescence fundus angiography (FFA) (Topcon TRC-50EX; Topcon, Tokyo, Japan), indocyanine green angiography (ICGA) (Heidelberg Spectralis HRA; Heidelberg Engineering, Heidelberg, Germany), or optical coherence tomography (OCT) (Zeiss-Humphrey, Dublin, CA). When confirmed by any of the three tests, the AMD patients would be included if they were 50 years or older and had no signs of other retinal diseases. Patients were excluded if they had polypoidal choroidal vasculopathy (PCV), myopia of 6.00 diopters (D) or above, macular dystrophy, central serous chorioretinopathy, any kind of vein occlusion, diabetic retinopathy, uveitis, other diseases involving malfunction of retinal photoreceptor cells, or serious chronic diseases. Visitors who went to the ophthalmologic department were taken as controls if they were 50 years or older, confirmed negative for AMD with fundus examination, had no signs of other retinal diseases, or had no serious chronic diseases. In the end, we recruited 535 unrelated Chinese patients with AMD and 469 controls ( Table 1) .
Classification of Age-Related Macular Degeneration
Fundus photographs taken at local hospitals were reviewed by the experts of People's Hospital. Stages of AMD were assigned based on the classification of the Age-Related Eye Disease Study (AREDS). 28 Early AMD was considered drusen with or without pigmentary abnormalities and in the absence of signs of advanced AMD. Advanced AMD was considered atrophic or neovascular AMD. Atrophic AMD was identified when geographic atrophy forms by depigmentation of the RPE and exposure of underlying choroidal vessels, and when neovascular AMD is absent. Neovascular AMD was identified when a patient had choroidal neovascularization (CNV), sensory retinal detachment, RPE serous/hemorrhagic detachment, subretinal/sub-RPE fibrosis, or disciform scars.
Genotyping
To analyze genetic polymorphisms of AMD, we selected 40 SNPs in 10 genes for their association with AMD (Table 2 ). Genomic DNA was extracted from the peripheral blood with a DNA extraction kit (DP319-01; Tiangen Biotech, Beijing, China). The PCR was performed on a thermal cycler (ABI GeneAmp 9700 384 Dual; ABI, Foster City, CA). Genotypes were analyzed with Typer 4.0 software (MassARRAY Compact System; Sequenom, San Diego, CA). All SNPs in this report had a genotyping success rate of >97%.
Statistical Analysis
We compared the genotypes of the AMD patients to those of the controls using the v 2 test. The adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the effect of genotype on the risk of AMD were estimated by the logistic regression analysis. Hardy-Weinberg equilibrium for each SNP polymorphism was tested by the v 2 test. All the above analyses were performed with SPSS software (version 15.0 for Windows; SPSS Inc., Chicago, IL). Permutation was used to correct for multiple testing. The linkage disequilibrium (LD), haplotypes (confidence intervals algorithm proposed by Gabriel et al. 29 ) and the corrected probabilities estimated by the permutation test were examined with Haploview software (provided in the public domain, http://www.broadinstitute.org/haploview/haploview, version 4.1, April, 2008). The adjusted ORs of the haplotypes were calculated by logistic regression analysis via PLINK software (provided in the public domain, http://pngu.mgh.harvard.edu/~purcell/plink, version 1.07, August 2009, accessed March 2011). P < 0.05 was considered statistically significant.
RESULTS
Of the 535 AMD patients 64 (12.0%) had early and 471 (88.0%) had advanced AMD. Among the patients with advanced AMD 464 (98.5%) had neovascular and 7 (1.5%) had atrophic AMD. There were more males in the patient group than in controls (P < 0.001) and the patients were significantly elder than controls (P < 0.001). There was no significant difference of the nationality between patients and controls (P ¼ 0.307). The percentage of patients among the participants in the north was higher than that of the south (P ¼ 0.025). There were more patients with family origin in the north than in the south (P ¼ 0.043, Table 3 ). Because a significant difference was found in sex, age, long-term residence, and family origin in patients and controls, the following estimation of ORs were adjusted by logistic regression analysis.
All 40 SNPs but rs173539 showed no significant deviation from Hardy-Weinberg equilibrium in the control group (P > 0.05). The genotype frequencies for patients and controls are shown in Table 4 . The risk allele frequencies of 11 SNPs tested in CFH, and 4 SNPs tested in ARMS2 and HTRA1 were significantly different between AMD patients and controls. The positive SNPs showed the same association with advanced and neovascular AMD. Other tested SNPs of C3, SERPING1, VEGF, CETP, LPL, LIPC, and TIMP3 did not reach the level of significance between AMD patients and controls.
The adjusted ORs, 95% CIs, and P values of the positive SNPs are shown in Table 5 . The homozygosity of risk alleles for five SNPs in CFH (rs551397, rs800292, rs10737680, rs2274700, rs1410996) and one SNP in ARMS2 (rs2736912) conferred a 2.11-fold (95% CI, 1.41-3.26), 2.13-fold (95% CI, 1.41-3.23), 2.01-fold (95% CI, 1.37-2.97), 2.26-fold (95% CI, 1.52-3.38), 2.08-fold (95% CI, 1.41-3.07), and 4.83-fold (95% CI, 1.31-17.83) increased likelihood of AMD. Five SNPs in CFH (rs1329424, rs1061170, rs10801555, rs10733086, rs380390), one in ARMS2 (rs10490924) as well as the two in HTRA1 (rs11200638, rs3793917) showed significant association with AMD for heterozygosity and homozygosity of risk alleles. The homozygosity of risk alleles for rs12124794 in CFH conferred a 1.63-fold (95% CI, 1.02-2.61) risk of advanced AMD.
With the exception of rs3753394, all SNPs genotyped in CFH were included within three haplotype blocks (see Fig.) . The frequencies, P values, and ORs for haplotypes with a frequency greater than 5% are shown in Table 6 . There were three SNPs within the first block: rs7524776 (intron), rs551397 (intron), and rs800292 (exon, Val62Ile). The haplotypes TGC and TAT showed significant association with AMD (TGC OR ¼ 1.52, P corr < 0.001 for all AMD, and OR ¼ 1.57, P corr < 0.001 for advanced AMD; TAT OR ¼ 0.64, P corr < 0.001 for all AMD, and OR ¼ 0.62, P corr < 0.001 for advanced AMD). After permutation, these two haplotypes remained significant. Block 2 contained seven SNPs: rs1329424 (intron), rs1061170 (exon, Tyr402His), rs10801555 (intron), rs12124794 (intron), rs6695321 (intron), rs10733086 (intron), and rs10737680 (intron). Only the haplotype ACAAAAA predisposed significantly to AMD after permutation (OR ¼ 1.92, P corr ¼ 0.001 for all AMD, and OR ¼ 2.05, P corr < 0.001 for advanced AMD). Block 3 contained four SNPs: rs2274700 (exon, Ala473Ala), rs3753396 (exon, Gln672Gln), rs1410996 (intron), and rs380390 (intron). The haplotypes TATG and CACC were associated significantly with AMD (TATG OR ¼ 0.63, P corr < 0.001 for all AMD, and OR ¼ 0.60, P corr < 0.001 for advanced AMD; CACC OR ¼ 2.27, P corr < 0.001 for all AMD, and OR ¼ 2.39, P corr < 0.001 for advanced AMD).
DISCUSSION
Our study described the genotype characteristics of AMD in a Chinese population, which revealed a significant association between AMD and CFH, ARMS2, and HTRA1 gene variants. With the current sample size, we did not find a significant association between AMD and the genetic variants of C3, SERPING1, VEGF, CETP, LPL, LIPC, and TIMP3 genes.
CFH has been identified by various studies as a major AMD susceptible gene in the Chinese, Japanese, and Caucasian populations, 7, 8, 11, 12, 26 which is consistent with our study. The frequency of the risk allele of rs1061170, which has been identified as an important genetic variant in CFH for developing AMD in Caucasians, is lower in the Chinese population (10.9% for C allele in our study) compared to Caucasians (34.9% for C allele). 30 This may explain why some studies, especially those with small sample size, failed to find the association between this SNP and AMD in Chinese populations. 8, 31 In our study, rs1061170 was associated significantly with AMD, though not as strong as in the Caucasian population. We also found out that other genetic variants in CFH, including rs551397, rs800292, rs1410996, * The OR hetero and P values were calculated by comparing the heterozygosity for the risk allele with the homozygosity for the normal allele, and adjusted for age (continuous variable), sex, long-term residence, and family origin by logistic regression analysis.
† The OR homo and P values were calculated by comparing the homozygosity for the risk allele with the homozygosity for the normal allele, and adjusted for age (continuous variable), sex, long-term residence, and family origin by logistic regression analysis. rs2274700, rs380390, rs1329424, rs10801555, and rs10737680, were associated with AMD, and this is consistent with some previous studies. 7, 8, 23, 26, [32] [33] [34] Moreover, our study found that rs12124794 and rs10733086 in CFH were associated significantly with AMD. Both of these SNPs are intron and their molecular effects still are not clear. After adjusting for rs2274700, rs12124794 did not reach the significant level (P ¼ 0.075). Meanwhile, after adjusting for rs1061170, rs10733086 did not reach the significant level (P ¼ 0.723). Therefore, these two SNPs might not associate with AMD independently and they might just reflect the effect of the known SNPs that are in linkage disequilibrium with them. Furthermore, we found three haplotype blocks. Each of the first two haplotypes contained one SNP that encoded for a missense amino acid change, whereas 2 SNPs in block 3 encoded for synonymous changes. The haplotypes composed by the detrimental alleles of SNPs that had significant association with AMD in the single association analysis conferred a 1.52 (TGC), 1.92 (ACAAAAA), and 2.27 (CACC)-fold increased risk of AMD, whereas the haplotypes that contained the non-detrimental alleles had evident protective effect. Our results regarding the block containing rs551397 and rs800292, and another block containing rs2274700 and rs3753396 are consistent with the previous reports. However, there was a difference in haplotypes between Caucasian and Asian populations. In Caucasians, rs1061170 was in the same block with rs551397 and rs800292, while studies in an Asian population, which were consistent with our results, found that rs1061170 did not occur in the same block with rs551397 and rs80029. 8, 33 In agreement with previous studies, we found that rs10490924 in ARMS2, and rs11200638 and rs3793917 in HTRA1 conferred strong susceptibility for AMD. The OR homo values in our study are similar to those of studies in a Caucasian population and some Chinese populations. 13, 31, 35 However, some other studies in Chinese populations revealed much higher ORs. 9, 10, 36, 37 DeWan et al reported that individuals with the risk-associated genotype were estimated to have a likelihood of wet AMD developing around 10 times (OR homo ¼ 11.14 for rs10490924, OR homo ¼ 10.00 for rs11200638) that of individuals with the wild-type genotype. 9 Yang et al found that individuals with the homo risk genotype were around 10-fold more likely to have AMD (OR homo ¼ 8.99 for rs10490924, OR homo ¼ 12.93 for rs11200638) than individuals without the risk genotype in a Han Chinese cohort. 10 This difference in the estimation of ORs might have resulted from the sample size or study design. In a word, no matter how great the OR, ARMS2 and HTRA1 conferred susceptibility for AMD.
Our study also revealed that the tested SNPs of C3, SERPING1, VEGF, CETP, LPL, LIPC, and TIMP3 were not associated significantly with AMD in a Chinese population, although they were associated with AMD in previous genomewide association studies (GWAS) or candidate studies in Caucasian populations. 14, 17, [19] [20] [21] [22] 38, 39 In a Chinese population, Liu et al indicated that none of the SNPs they tested in C3 showed significant association with AMD, 7 while Pei et al showed that the G allele of C3 (rs2250656) might be a significant protective factor for neovascular AMD. 40 Most studies in Chinese and Japanese populations did not provide evidence for the role of VEGF to AMD, 25, 26 and this is consistent with our results. However, Lin et al reported that VEGF-rs3025039 polymorphisms were associated dependently with wet AMD in the Taiwan Chinese population. 27 This disagreement with our study possibly is due to the difference in inclusion and exclusion criteria of the two studies. In addition, our study in a Chinese population concerned the relationship about AMD, and genetic variants of CETP, LPL, LIPC, and TIMP3, though no significant association was disclosed. This disagrees with results of studies in Caucasians, [20] [21] [22] which might be due to the fact that we only included a few SNPs of the above genes, possibly missing some other SNPs that could have an effect. Besides, with our sample size, the powers of the negative associations were less than 0.5, which was not adequate to state the negative association. Based on the above situations, further study with more SNPs and larger sample size may be needed.
Strengths of our study include the large, nationwide, wellcharacterized Chinese patients, classification of AMD by standardized ophthalmologic examinations, and the reading center. Besides, to our knowledge, this is the first study to examine the association on the genetic variants of rs12124794, rs10733086, rs6695321, and rs7524776 in CFH; rs2736912 in ARMS2; rs408290, rs8112351, rs11569562, and rs7257062 in C3; and rs2303789, rs17231506, rs1532625, rs289744, and rs9939224 in CETP to AMD, as well as the first study to examine the association on the genetic variants of rs12678919 nearby LPL, rs10468017 nearby LIPC, and rs9621532 nearby TIMP3 to AMD in the Chinese population.
In conclusion, we confirmed that CFH, ARMS2, and HTRA1 genetic variants were related to risk of AMD in the Chinese population. Further research is needed to explore the interaction of heredity and environment, so that the pathogenic mechanisms of AMD can be featured and intervened.
